Product image of Memantine Ratiopharm (Memantine Hydrochloride) supplied by GNH India

Memantine Ratiopharm

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantine Ratiopharm (Memantine Hydrochloride)

Memantine Hydrochloride, the active ingredient in Memantine Ratiopharm, is an NMDA receptor antagonist presented as an oral tablet for oral administration. It is indicated for the symptomatic treatment of moderate to severe Alzheimer’s disease in adult patients, helping to improve cognition and daily functioning.

GNH India supplies Memantine Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards. Our quality‑assured supply chain ensures product integrity from manufacturing to end‑user.

Manufacturer / TM Owner

Ratiopharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantine Ratiopharm is used in the management of neurodegenerative disorders, specifically Alzheimer’s disease, by modulating glutamatergic activity.

  • Alzheimer’s disease: improves cognition, daily functioning and behavioral symptoms in patients with moderate to severe disease.

How It Works

  • Memantine Hydrochloride acts as a non‑competitive antagonist at the NMDA (N‑methyl‑D‑aspartate) receptor. By binding to the receptor-associated ion channel with moderate affinity, it blocks excessive calcium influx caused by overstimulation with glutamate, thereby reducing excitotoxic neuronal injury while preserving normal synaptic transmission.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Dizziness: transient feeling of light‑headedness.
  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Confusion: temporary mental clouding.
  • Fatigue: increased tiredness.
  • Hypertension: elevated blood pressure readings.

Serious or Rare Side Effects

  • Seizures: occurrence of convulsive episodes.
  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Hallucinations: visual or auditory disturbances.
  • Suicidal thoughts: emergence of depressive ideation.
  • Cardiac arrhythmia: irregular heart rhythm.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors.

  • Renal impairment: assess kidney function and consider dose adjustment.
  • Hepatic impairment: monitor liver enzymes and adjust therapy as needed.
  • History of seizures: use with caution and observe for seizure activity.
  • Concomitant NMDA antagonists: avoid combined use to reduce additive toxicity.
  • Pregnancy: safety not established; weigh potential benefits against risks.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Memantine may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid)

  • Amantadine: increased risk of dizziness and confusion.
  • Ketamine: additive NMDA antagonism may amplify neuro‑psychiatric effects.
  • Other NMDA antagonists: combined use can lead to excessive receptor blockade.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may enhance dizziness or headache.
  • Anticholinergic agents: possible reduction in memantine efficacy.
  • Diuretics: potential for orthostatic hypotension.

Frequently Asked Questions

Memantine Ratiopharm contains memantine hydrochloride and is prescribed for the symptomatic treatment of moderate to severe Alzheimer’s disease. It helps improve cognitive function, daily activities, and behavioral symptoms in adult patients.

Memantine acts as a non‑competitive antagonist at NMDA receptors, blocking excessive calcium entry caused by glutamate over‑activation. This reduces excitotoxic neuronal damage while allowing normal synaptic transmission, which can help preserve cognitive function.

The specific dose and titration schedule are determined by the prescribing clinician based on the patient’s condition, renal function, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for memantine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Memantine belongs to the NMDA‑receptor antagonist class, whereas many other Alzheimer’s agents are acetylcholinesterase inhibitors (e.g., donepezil). Memantine targets excitotoxic pathways, offering a different mechanism that can be used alone or in combination with cholinergic agents for broader symptom control.

Store the tablets at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and heat sources to maintain product stability.

Memantine Ratiopharm is taken orally, usually as a tablet swallowed with water. The exact dosing schedule (once daily or divided doses) is set by the prescriber based on individual patient needs.

Serious risks include seizures, severe allergic reactions, hallucinations, suicidal thoughts, and cardiac arrhythmias. Patients should be monitored for any new or worsening neurological or cardiac symptoms and seek medical attention promptly if they occur.

Memantine is contraindicated in patients with known hypersensitivity to memantine or any component of the formulation. Caution is advised for individuals with severe renal impairment, uncontrolled epilepsy, or those taking other NMDA antagonists.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT